Clinical Trial Update: A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a phase 1/2 study evaluating the combination of inotuzumab ozogamicin and blinatumomab in people with B-cell acute lymphoblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)
• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: B-cell Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING